Handelsbanken Fonder’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Sell |
200,000
-15,900
| -7% | -$111K | ﹤0.01% | 805 |
|
|
2025
Q1 | $1.83M | Hold |
215,900
| – | – | 0.01% | 683 |
|
|
2024
Q4 | $3.02M | Sell |
215,900
-2,800
| -1% | -$39.2K | 0.01% | 548 |
|
|
2024
Q3 | $4.95M | Buy |
218,700
+5,200
| +2% | +$118K | 0.02% | 438 |
|
|
2024
Q2 | $4.32M | Buy |
213,500
+33,700
| +19% | +$682K | 0.02% | 438 |
|
|
2024
Q1 | $4.48M | Buy |
179,800
+40,000
| +29% | +$996K | 0.02% | 463 |
|
|
2023
Q4 | $2.53M | Buy |
139,800
+5,300
| +4% | +$95.8K | 0.01% | 512 |
|
|
2023
Q3 | $2.7M | Hold |
134,500
| – | – | 0.02% | 500 |
|
|
2023
Q2 | $3.43M | Buy |
134,500
+2,700
| +2% | +$68.9K | 0.02% | 463 |
|
|
2023
Q1 | $2.8M | Hold |
131,800
| – | – | 0.02% | 486 |
|
|
2022
Q4 | $3.9M | Buy |
131,800
+1,800
| +1% | +$53.3K | 0.02% | 439 |
|
|
2022
Q3 | $3.02M | Hold |
130,000
| – | – | 0.02% | 472 |
|
|
2022
Q2 | $2.18M | Hold |
130,000
| – | – | 0.01% | 518 |
|
|
2022
Q1 | $5.7M | Buy |
130,000
+50,000
| +63% | +$2.19M | 0.03% | 436 |
|
|
2021
Q4 | $4.87M | Buy |
+80,000
| New | +$4.87M | 0.02% | 477 |
|